Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07367958
PHASE1

A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects

Sponsor: Celltrion

View on ClinicalTrials.gov

Summary

This is phase 1 study to Compare the Pharmacokinetics, Safety and Immunogenicity of the Auto-injector and Pre-filled syringe of CT-P52 in Healthy Male Subjects.

Official title: A Phase 1, Randomized, Open-label, Two-arm, Parallel-Group, Single-dose Study to Compare Pharmacokinetics and Safety of CT-P52 AI and CT-P52 PFS in Healthy Male Subjects

Key Details

Gender

MALE

Age Range

19 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

218

Start Date

2026-01

Completion Date

2027-01

Last Updated

2026-01-26

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

CT-P52

CT-P52, 80 mg in 1 ml, a single subcutaneous (SC) injection via auto-injector (AI)